Skip to main content
. 2016 Dec;8(12):3667–3675. doi: 10.21037/jtd.2016.12.38

Table 4. Clinical characteristics of male pneumothorax patients with MMP-2 and MMP-9 expression.

Variables Item Patient No. (%) MMP-2 MMP-9
Low High P valuea Low High P valuea
No. % No. % No. % No. %
Age (years) ≤20 48 (60.8) 14 29.2 34 70.8 0.556 21 43.8 27 56.2 0.902
>20 31 (39.2) 11 35.5 20 64.5 14 45.2 17 54.8
BMI (kg/m2) <18 31 (39.2) 9 29.0 22 71.0 0.688 13 41.9 18 58.1 0.733
≥18 48 (60.8) 16 33.3 32 66.7 22 45.8 26 54.2
Recurrence No 37 (46.8) 20 54.1 17 45.9 <0.001 24 64.9 13 35.1 0.001
Yes 42 (53.2) 5 11.9 37 88.1 11 26.2 31 73.8
Smoking status No 64 (81.0) 24 37.5 40 62.5 0.029 32 50.0 32 50.0 0.045
Yes 15 (19.0) 1 6.7 14 93.3 3 20.0 12 80.0
Side involved Unilateral 55 (69.6) 16 29.1 39 70.9 0.460 26 47.3 29 52.7 0.421
Bilateral 24 (30.4) 9 37.5 15 62.5 9 37.5 15 62.5

a, the P value was calculated by the chi-square test. MMP-2, matrix metalloproteinase-2; MMP-9, matrix metalloproteinase-9; BMI, body mass index.